-
Posted: January 26th, 2023, 3:00pm GMT
Conditions: Astroblastoma; BCOR ITD Sarcoma; CNS Sarcoma; Unclassified Tumor, Malignant
Intervention:
Sponsor: Children's National Research Institute
Recruiting
-
Posted: January 26th, 2023, 3:00pm GMT
Condition: Glioma
Intervention: Diagnostic Test: MRI
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Not yet recruiting
-
Posted: January 26th, 2023, 3:00pm GMT
Conditions: Recurrent High Grade Glioma; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Glioblastoma; Gliosarcoma
Interventions: Drug: PCI 24781; Drug: Temozolomide
Sponsors: University of Nebraska; Xynomic Pharmaceuticals, Inc.
Not yet recruiting
-
Posted: January 26th, 2023, 3:00pm GMT
Condition: Brain Metastases
Interventions: Drug: Niraparib; Drug: Dostarlimab
Sponsor: M.D. Anderson Cancer Center
Not yet recruiting
-
Posted: January 24th, 2023, 3:00pm GMT
Conditions: Glioblastoma; Glioma, Malignant
Intervention:
Sponsors: Duke University; Personalis, Inc.
Not yet recruiting
-
Posted: January 20th, 2023, 3:00pm GMT
Conditions: Brain Metastases; Nonsmall Cell Lung Cancer Stage III
Interventions: Diagnostic Test: MRI of the Brain; Other: Blood draws; Other: Quality of Life Questionnaires
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: January 19th, 2023, 3:00pm GMT
Conditions: Brain Metastases, Adult; Non Small Cell Lung Cancer; Breast Cancer
Interventions: Dietary Supplement: Silibinin; Other: Placebo
Sponsor: Alessia Pellerino
Recruiting
-
Posted: January 18th, 2023, 3:00pm GMT
Conditions: Tumor, Brain; Tumor, Breast; Tumor Skin
Intervention:
Sponsor: National Taiwan University Hospital
Not yet recruiting
-
Posted: January 18th, 2023, 3:00pm GMT
Conditions: Epilepsy; Cerebral Tumor
Intervention: Other: use of a theremin-type musical instrument
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Not yet recruiting
-
Posted: January 16th, 2023, 3:00pm GMT
Conditions: Malignant Glioma of Brain; Astrocytoma; Malignant Astrocytoma; Brain Tumor; Glioma; Brain Cancer; Glioblastoma; Glioblastoma Multiforme; GBM
Intervention: Biological: Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
Sponsor: Henry Ford Health System
Recruiting
-
Posted: January 13th, 2023, 3:00pm GMT
Condition: Glioblastoma Multiforme of Brain
Interventions: Biological: TVI-Brain-1; Procedure: Standard of Care; Radiation: Radiotherapy; Drug: Temozolomide
Sponsor: TVAX Biomedical
Not yet recruiting
-
Posted: January 10th, 2023, 3:00pm GMT
Condition: Intracranial Tumors
Intervention: Device: early detection test
Sponsors: Zhujiang Hospital; Guangzhou Burning Rock Dx Co., Ltd.
Recruiting
-
Posted: January 9th, 2023, 3:00pm GMT
Conditions: Healthy Volunteers; Recurrent Glioma; Brain Metastases From Extra-cranial Solid Tumors
Intervention: Drug: [F-18]MeFAMP PET
Sponsor: University of Alabama at Birmingham
Not yet recruiting
-
Posted: January 6th, 2023, 3:00pm GMT
Conditions: Metastatic Solid Tumor; Brain Metastases
Interventions: Drug: Trastuzumab emtansine; Drug: Tucatinib
Sponsors: M.D. Anderson Cancer Center; Genentech, Inc.; Seagen Inc.
Not yet recruiting
-
Posted: January 5th, 2023, 3:00pm GMT
Conditions: Medulloblastoma; Central Nervous System Tumor, Pediatric; Ependymoma; Germ Cell Tumor; Glioma; Brain Tumor, Pediatric
Intervention:
Sponsor: Beijing Tiantan Hospital
Recruiting
-
Posted: January 2nd, 2023, 3:00pm GMT
Condition: Glioblastoma
Interventions: Dietary Supplement: Salovum; Dietary Supplement: Placebo egg yolk powder
Sponsors: Peter Siesjö; Lund University
Recruiting
-
Posted: December 30th, 2022, 3:00pm GMT
Condition: Malignant Brain Tumor
Intervention: Other: NODDI TRACT
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche
Not yet recruiting
-
Posted: December 30th, 2022, 3:00pm GMT
Condition: Melanoma Metastatic in the Brain
Interventions: Drug: CA-4948; Drug: Pembrolizumab
Sponsors: University of Florida; Merck Sharp & Dohme LLC
Not yet recruiting
-
Posted: December 23rd, 2022, 3:00pm GMT
Condition: Glioblastoma
Interventions: Biological: Autologous genetically modified gamma-delta T cells; Biological: Allogeneic genetically modified gamma-delta T cells
Sponsor: In8bio Inc.
Not yet recruiting
-
Posted: December 23rd, 2022, 3:00pm GMT
Condition: Glioblastoma
Interventions: Drug: Gabapentin; Drug: Sulfasalazine; Drug: Memantine; Drug: Temozolomide; Radiation: Radiotherapy
Sponsors: University of Zurich; Swiss National Science Foundation
Not yet recruiting
-
Posted: December 21st, 2022, 3:00pm GMT
Condition: Primary Brain Tumor
Intervention:
Sponsor: University Hospital, Strasbourg, France
Recruiting
-
Posted: December 21st, 2022, 3:00pm GMT
Conditions: Brain Tumor; Head and Neck Cancer
Interventions: Radiation: substructure informed planning; Other: Neurocognitive Testing; Diagnostic Test: MRI
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not yet recruiting
-
Posted: December 21st, 2022, 3:00pm GMT
Condition: Pituitary Tumor
Intervention: Other: Nasal saline irrigation
Sponsors: Nicole Hill; Barrow Brain and Spine
Recruiting
-
Posted: December 16th, 2022, 3:00pm GMT
Condition: Glioblastoma Multiforme, Adult
Intervention: Procedure: Integrated boost technique (SIB) guided by PET FDOPA
Sponsor: Institut de cancérologie Strasbourg Europe
Not yet recruiting
-
Posted: December 16th, 2022, 3:00pm GMT
Condition: Glioblastoma
Intervention: Radiation: Simultaneous-integrated boost with IMRT
Sponsors: Institut de cancérologie Strasbourg Europe; Centre Georges François Leclerc
Not yet recruiting
-
Posted: December 15th, 2022, 3:00pm GMT
Condition: Small Cell Lung Cancer Limited Stage
Interventions: Radiation: Prophylactic cranial irradiation; Radiation: Thoracic radiotherapy; Drug: Chemotherapy
Sponsors: Zhejiang Cancer Hospital; Sun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University
Not yet recruiting
-
Posted: December 7th, 2022, 3:00pm GMT
Condition: Metastatic Melanoma
Intervention: Biological: Lifileucel (LN-144)
Sponsors: Memorial Sloan Kettering Cancer Center; Iovance Biotherapeutics, Inc.
Recruiting
-
Posted: November 17th, 2022, 3:00pm GMT
Condition: Brain Metastases, Adult
Intervention: Drug: Patritumab deruxtecan
Sponsors: Mustafa Khasraw, MBChB, MD, FRCP, FRACP; Daiichi Sankyo, Inc.
Not yet recruiting
-
Posted: October 27th, 2022, 2:00pm GMT
Conditions: Non Hodgkin Lymphoma; Heart; Functional Disturbance; Hodgkin Lymphoma; Quality of Life
Interventions: Other: Exercise with Trainerize application; Diagnostic Test: Cardiopulmonary exercise testing; Diagnostic Test: MRI scan; Behavioral: Quality of Life Questionnaires; Behavioral: Cognitive and Brain Function Questionnaires; Other: Blood draws
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Recruiting
-
Posted: August 17th, 2022, 2:00pm GMT
Conditions: Childhood Cancer; Childhood Solid Tumor; Childhood Brain Tumor; Childhood Leukemia; Refractory Cancer; Relapsed Cancer
Interventions: Genetic: Whole Genome Sequencing; Genetic: RNA seq; Genetic: DNA Methylation; Genetic: Targeted Panel Sequencing; Genetic: High Throughput Sequencing (in vitro); Genetic: Patient Derived Xenograft (PDX)(in vivo); Other: Liquid Biopsy
Sponsors: Australian & New Zealand Children's Haematology/Oncology Group; Children's Cancer Institute; Minderoo Foundation; Medical Research Future Fund
Recruiting
-
Posted: August 15th, 2022, 2:00pm GMT
Conditions: Cancer; Solid Tumor; Solid Carcinoma; Advanced Cancer; DIPG Brain Tumor; Ovary Cancer; Breast Cancer; Papillary Thyroid Cancer; Head and Neck Cancer; Gastric Cancer; Nsclc; Mesotheliomas Pleural; Mesothelioma Peritoneum; Esophageal Cancer; Diffuse Midline Glioma, H3 K27M-Mutant; Endometrial Cancer; Cervical Cancer; Melanoma; Colorectal Cancer
Interventions: Drug: AMXT1501; Drug: DFMO
Sponsor: Aminex Therapeutics, Inc.
Recruiting
-
Posted: July 1st, 2022, 2:00pm GMT
Conditions: Tumor, Cerebral Ventricle; Tumor, Cerebellar; Aneurysm Cerebral; Trauma, Brain
Intervention: Device: Lyoplant®
Sponsor: Aesculap AG
Not yet recruiting
-
Posted: May 26th, 2022, 2:00pm GMT
Conditions: Astrocytoma; Oligodendroglioma, Adult; Glioma, Malignant
Intervention: Radiation: temporally-modulated pulsed radiotherapy (TMPRT)
Sponsor: Washington University School of Medicine
Recruiting
-
Posted: May 23rd, 2022, 2:00pm GMT
Conditions: Breast Neoplasms; Brain Neoplasms; Neoplasms by Site; Neoplasms; Breast Diseases; Central Nervous System Neoplasms; Brain Diseases; Central Nervous System Diseases
Interventions: Drug: Elacestrant; Drug: Abemaciclib
Sponsor: Stemline Therapeutics, Inc.
Recruiting
-
Posted: May 20th, 2022, 2:00pm GMT
Conditions: Glioblastoma; Glioma; Liquid Biopsy
Intervention: Device: Focused Ultrasound (Exablate Model 4000)
Sponsor: InSightec
Recruiting
-
Posted: May 18th, 2022, 2:00pm GMT
Condition: Newly Diagnosed Glioblastoma
Intervention: Drug: combinations of up to 3 FDA approved drugs from a panel of compounds
Sponsor: Swedish Medical Center
Not yet recruiting
-
Posted: April 28th, 2022, 2:00pm GMT
Conditions: Cancer; Hereditary Neoplasms; Genetic Predisposition to Cancer; Environment
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: March 16th, 2022, 2:00pm GMT
Condition: Glioma, Malignant
Interventions: Biological: Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine; Drug: Hiltonol
Sponsors: Mustafa Khasraw, MBChB, MD, FRCP, FRACP; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: October 21st, 2021, 2:00pm GMT
Conditions: GBM; Glioma Glioblastoma Multiforme; Tumor, Brain
Intervention: Diagnostic Test: Whole Brain Spectroscopy Imaging Array Mapping Layout
Sponsors: Abramson Cancer Center of the University of Pennsylvania; NovoCure Ltd.; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting
-
Posted: August 6th, 2021, 2:00pm GMT
Conditions: Atypical Choroid Plexus Papilloma; Choroid Plexus Carcinoma
Interventions: Drug: Melphalan; Drug: Carboplatin; Drug: Topotecan
Sponsor: Weill Medical College of Cornell University
Recruiting
-
Posted: August 3rd, 2021, 2:00pm GMT
Conditions: Central Nervous System Neoplasm; Leptomeningeal Neoplasm; Metastatic Malignant Neoplasm in the Brain; Primary Brain Neoplasm
Interventions: Other: Electronic Health Record Review; Other: Survey Administration
Sponsor: M.D. Anderson Cancer Center
Recruiting
-
Posted: July 26th, 2021, 2:00pm GMT
Condition: Glioblastoma Multiforme
Interventions: Drug: Pembrolizumab; Radiation: Stereotactic Radiation Therapy; Procedure: Surgical Resection
Sponsors: Chirag G. Patil; Merck Sharp & Dohme LLC; National Cancer Institute (NCI)
Recruiting
-
Posted: July 23rd, 2021, 2:00pm GMT
Condition: Glioma
Intervention: Device: RS-fMRI
Sponsors: Washington University School of Medicine; The Foundation for Barnes-Jewish Hospital
Recruiting
-
Posted: May 25th, 2021, 2:00pm GMT
Conditions: Glioblastoma; Glioblastoma Multiforme
Interventions: Drug: Ferumoxytol injection; Drug: Pharmacological ascorbate; Radiation: External beam radiation therapy; Drug: Temozolomide
Sponsors: Bryan Allen; Holden Comprehensive Cancer Center; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: May 18th, 2021, 2:00pm GMT
Conditions: Neurocognitive Deficit; Quality of Life; Activities of Daily Living
Interventions: Radiation: Stereotactic RadioTherapy; Radiation: Whole Brain Irradiation
Sponsors: Mediterranean Institute of Oncology; University of Messina; University of Palermo
Recruiting
-
Posted: March 23rd, 2021, 2:00pm GMT
Condition: Brain Neoplasm
Intervention: Procedure: Brain Surgery
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting
-
Posted: March 22nd, 2021, 2:00pm GMT
Condition: Prostate Cancer
Intervention: Device: TULSA-PRO
Sponsor: National Cancer Institute (NCI)
Not yet recruiting
-
Posted: February 5th, 2021, 3:00pm GMT
Conditions: Glioblastoma; Glioma, Malignant
Intervention: Biological: MT-201-GBM monocyte vaccine
Sponsors: Michael Gunn; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: January 26th, 2021, 3:00pm GMT
Condition: Tumor, Solid
Intervention: Drug: Indocyanine Green
Sponsor: University of Pennsylvania
Not yet recruiting
-
Posted: October 14th, 2020, 2:00pm GMT
Conditions: Brain Tumor; Post-Op Complication; Anesthesia
Interventions: Other: Quality of Recovery-15; Other: Glasgow Result Scale; Other: Risk Factors
Sponsor: Trakya University
Recruiting
-
Posted: August 12th, 2020, 2:00pm GMT
Conditions: Acral Lentiginous Melanoma; Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Cutaneous Melanoma; Metastatic Malignant Neoplasm in the Brain; Metastatic Melanoma; Metastatic Mucosal Melanoma; Pathologic Stage IV Cutaneous Melanoma AJCC v8
Interventions: Drug: Binimetinib; Drug: Encorafenib; Biological: Ipilimumab; Biological: Nivolumab
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting
-
Posted: July 17th, 2020, 2:00pm GMT
Condition: Brain Metastases
Interventions: Procedure: Brain Surgery; Radiation: Stereotactic Radiosurgery
Sponsor: AHS Cancer Control Alberta
Recruiting
-
Posted: July 17th, 2020, 2:00pm GMT
Conditions: Brain Tumor; Neurofibromatoses; Sarcoma; Leukemia; Hematologic Diseases; Neuroblastoma
Intervention: Other: "My Logbook! - I know my way around!"
Sponsors: Medical University of Vienna; St. Anna Kinderspital, Austria; Charite University, Berlin, Germany; Cnopfsche Kinderklinik, Nürnberg; Kepler University Hospital; University Hospital, Saarland; Hannover Medical School; Krankenhaus Bozen; University Hospital Frankfurt; Universitätsklinikum Hamburg-Eppendorf; Universitätsklinikum Leipzig; University Hospital Muenster; University Hospital Tuebingen; Salzburger Landeskliniken; Leuwaldhof St.Veit (Kinder- und Jugendreha); University Hospital, Essen; Medical University of Graz; University Hospital Erlangen; Wuerzburg University Hospital; Klinik Bad Oexen, Germany; Universitätsklinikum Köln; University Hospital Schleswig-Holstein; University Hospital Carl Gustav Carus; Universitätsmedizin Mannheim; University Hospital Regensburg; Luca-Dethlefsen-Hilfe e.V.; University Hospital Inselspital, Berne; Staedtisches Klinikum Karlsruhe
Recruiting
-
Posted: June 16th, 2020, 2:00pm GMT
Conditions: Familial Cancer; BRCA1-Associated Protein-1 (BAP1) Mutations; Tumor Predisposition Syndrome (TPDS); Mesothelioma
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: May 18th, 2020, 2:00pm GMT
Condition: Glioblastoma
Interventions: Drug: Gliolan; Device: Intraoperative PDT
Sponsors: University Hospital, Lille; Institut National de la Santé Et de la Recherche Médicale, France; Hemerion Therapeutics
Recruiting
-
Posted: April 16th, 2020, 2:00pm GMT
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Malignant Neoplasm in the Brain; Metastatic Triple-Negative Breast Carcinoma; Prognostic Stage IV Breast Cancer AJCC v8
Interventions: Biological: Anti-HER2/HER3 Dendritic Cell Vaccine; Biological: Pembrolizumab
Sponsors: Roswell Park Cancer Institute; United States Department of Defense
Recruiting
-
Posted: February 13th, 2020, 3:00pm GMT
Condition: Brain Cancer
Interventions: Behavioral: eSNAP; Behavioral: Caregiver Navigator
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Recruiting
-
Posted: September 30th, 2019, 2:00pm GMT
Condition: CNS Metastases
Interventions: Other: Samples collection: Plasma; Other: Samples collection: CSF; Other: Samples collection: Non-CNS Metastatic Tumour Tissue; Other: Brain MRI; Other: Samples collection: Serum
Sponsors: Jules Bordet Institute; La Fondation contre le cancer, Belgique; Les Amis de l'Institut Bordet; Bristol-Myers Squibb; Fondation Cancer, Luxembourg
Recruiting
-
Posted: September 23rd, 2019, 2:00pm GMT
Conditions: Diffuse Intrinsic Pontine Glioma; High Grade Glioma; Embryonal Tumor; Ependymal Tumor
Interventions: Genetic: (C7R)-GD2.CART cells; Drug: Cyclophosphamide; Drug: Fludarabine
Sponsors: Baylor College of Medicine; Center for Cell and Gene Therapy, Baylor College of Medicine; The Faris Foundation
Recruiting
-
Posted: November 15th, 2018, 3:00pm GMT
Conditions: Malignant Neoplasm; Metastatic Malignant Neoplasm in the Brain
Interventions: Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Radiation: Stereotactic Radiosurgery
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: September 19th, 2018, 2:00pm GMT
Condition: Pituitary Neoplasm
Intervention: Other: ESC
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting
-
Posted: February 6th, 2018, 3:00pm GMT
Conditions: Recurrent Glioblastoma Multiforme; Primary Glioblastoma Multiforme; Brain Neoplasms, Malignant; Leptomeningeal Disease (LMD)
Interventions: Radiation: Radiation Therapy; Drug: AZD1390
Sponsor: AstraZeneca
Recruiting
-
Posted: November 1st, 2017, 2:00pm GMT
Condition: Breast Cancer Metastatic
Intervention: Drug: Irinotecan Hydrochloride
Sponsor: MedSIR
Recruiting
-
Posted: September 11th, 2017, 2:00pm GMT
Condition: Glioblastoma, Adult
Interventions: Drug: Pembrolizumab at 7 days prior; Drug: Pembrolizumab at 14 days post; Drug: Pembrolizumab at 35 days post; Procedure: Laser Interstitial Thermotherapy
Sponsor: Case Comprehensive Cancer Center
Recruiting
-
Posted: February 9th, 2017, 3:00pm GMT
Condition: Ion Beam Radiation Therapy for Tumor Patients
Intervention: Radiation: Protons and Carbon Ions
Sponsor: EBG MedAustron GmbH
Recruiting
-
Posted: December 31st, 2015, 3:00pm GMT
Conditions: Diffuse Intrinsic Pontine Glioma; Brain Tumor, Recurrent; Solid Tumor, Recurrent; Neuroblastoma, Recurrent, Refractory; Ewing Sarcoma, Recurrent, Refractory; Rhabdomyosarcoma, Recurrent, Refractory; Osteosarcoma, Recurrent, Refractory; Rhabdoid Tumor, Recurrent, Refractory
Intervention: Drug: Abemaciclib
Sponsor: Emory University
Recruiting
-
Posted: November 13th, 2014, 3:00pm GMT
Conditions: Pituitary Neoplasms; Adenoma
Intervention: Drug: cabergoline
Sponsors: St. Olavs Hospital; Norwegian University of Science and Technology
Recruiting